O'Shaughnessy Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $289K | Buy |
+10,492
| New | +$289K | ﹤0.01% | 1655 |
|
2024
Q4 | – | Sell |
-9,418
| Closed | -$544K | – | 2259 |
|
2024
Q3 | $544K | Sell |
9,418
-9,982
| -51% | -$576K | ﹤0.01% | 1192 |
|
2024
Q2 | $2.3M | Buy |
19,400
+8,531
| +78% | +$1.01M | 0.02% | 560 |
|
2024
Q1 | $1.16M | Buy |
10,869
+3,148
| +41% | +$335K | 0.01% | 772 |
|
2023
Q4 | $768K | Buy |
7,721
+57
| +0.7% | +$5.67K | 0.01% | 839 |
|
2023
Q3 | $792K | Buy |
7,664
+1,945
| +34% | +$201K | 0.01% | 762 |
|
2023
Q2 | $695K | Buy |
5,719
+33
| +0.6% | +$4.01K | 0.01% | 768 |
|
2023
Q1 | $873K | Sell |
5,686
-3,839
| -40% | -$590K | 0.01% | 693 |
|
2022
Q4 | $1.71M | Buy |
9,525
+5,556
| +140% | +$998K | 0.03% | 461 |
|
2022
Q3 | $469K | Buy |
3,969
+139
| +4% | +$16.4K | 0.01% | 759 |
|
2022
Q2 | $547K | Sell |
3,830
-500
| -12% | -$71.4K | 0.01% | 667 |
|
2022
Q1 | $746K | Buy |
4,330
+934
| +28% | +$161K | 0.01% | 614 |
|
2021
Q4 | $863K | Sell |
3,396
-436
| -11% | -$111K | 0.02% | 543 |
|
2021
Q3 | $1.48M | Buy |
3,832
+2,073
| +118% | +$798K | 0.03% | 380 |
|
2021
Q2 | $413K | Buy |
1,759
+746
| +74% | +$175K | 0.01% | 734 |
|
2021
Q1 | $133K | Buy |
1,013
+279
| +38% | +$36.6K | ﹤0.01% | 1082 |
|
2020
Q4 | $77K | Buy |
734
+621
| +550% | +$65.1K | ﹤0.01% | 1142 |
|
2020
Q3 | $8K | Buy |
113
+4
| +4% | +$283 | ﹤0.01% | 1408 |
|
2020
Q2 | $7K | Buy |
+109
| New | +$7K | ﹤0.01% | 1323 |
|
2019
Q3 | – | Sell |
-1
| Closed | – | – | 1144 |
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1134 |
|